Global effort to unlock secrets of rare childhood cancer
NCT ID NCT00700414
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study collects medical and family history from children and teens with adrenocortical tumors, a rare cancer. Researchers also study tumor samples to learn about genetic factors like the TP53 gene. The goal is to better understand the disease and improve care worldwide.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help doctors better understand and treat this rare childhood cancer, potentially improving future outcomes.
- What could go wrong
- This is an observational registry, not a treatment trial. It collects information but does not test any new therapy, so direct benefits to participants are unlikely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADRENOCORTICAL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
All Children's Hospital/St. Petersburg Hospital
COMPLETEDSt. Petersburg, Florida, 33701, United States
-
Cook Children's Medical Center
COMPLETEDFort Worth, Texas, 76104, United States
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Email: •••••@•••••
-
Stanford University
COMPLETEDStanford, California, 94305, United States
-
The Children's Medical Center
RECRUITINGDayton, Ohio, 45404, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.